We bring together exceptional science, business, startup and finance experience, as well as deep international longevity network.

Petr has been a serial entrepreneur for more than 33 years and believes that science and technology can help humanity reach a new, better level of being. He is building science, funding, and business infrastructure to support faster adoption of health-span improving technologies. He is a founder of Longevitytech.fund, former Entrepreneur in Residence at Singularity University, co-founder of the Longevityforum.eu, board member at Animal Biosciences (US), AgeCurve (UK), iamYiam (UK). He helps innovative teams in the Longevity sector grow into confident companies with global ambitions. He provides advice on fundraising, strategy, and product management. He advises companies as a mentor at Foresight Institute and On Deck Longevity Biotech.

Founder and Editor in Chief of Investicniweb.cz (from 2009) - the leading investment news platform in Czech. 12 year of experience as licensed SE trader at Eastbrokers, Merrill Lynch, Citibank a HVB Bank. He also manages investment fairs like Investment forum and Trading Expo and TV shows O2 TV a Byznys index. He successfully managed his previous real estate fund to more than 200% ROI. He graduated on American Institute of Arts and Science with a specialization on portfolio management (MBA).

Vladislav Severa has spent almost two decades in the field of Corporate Finance, having worked on a number of premiere deals in the CEE region and leading the regional Transaction Advisory team of a Big Four firm, before establishing and leading also its CE Advanced Analytics practice. More recently, Vladislav has been active as a founder or sponsor of AI-aided start-ups in education technology. Vladislav graduated in Physics from Charles University in Prague, where he also earned Ph.D. in Mathematics, and is joining Longevitytech.fund as a co-founder.

Head of IBM Watson AI R&D Lab, Prague. Skilled in managing international research and engineering around AI, natural language processing, speech and conversational technologies. Strong and seasoned professional with a Doctor of Philosophy - PhD focused in Mathematics and Computer Science from Charles University in Prague. Jan has 40+ international patents and many scientific publications around AI.

Expert in pharmaceutical, regulatory, and antitrust law. She leads Taylor Wessing's CEE Life Science team. Before joining Novartis Oncology she spent five years as Head of CEE Competition at CMS Cameron McKenna (during which she was seconded for almost three years to Amazon), two years at Weinhold Legal and four and a half years with Clifford Chance. She studied law in several European cities as well as in Australia and acquired LL.M. Degree from Cambridge University and Ph.D in law from the Charles University in Prague.

CEO of technology transfer office IOCBTech and vice-president of Institute of Organic Chemistry and Biochemistry of Czech Science Academy. He is also the chairman of grant committee of Czech Technology Agency and university professor of biochemistry. His work is rooted in basic research and research commercialization. He authored more than 50 papers and published two monographies.

Professor of environmental chemistry and the director of RECETOX. She has vast research experience in the field of environmental health and the impacts of toxic substances on health. She currently coordinates the CETOCOEN Excellence project, which aims to build a European Center of Excellence for Environmental and Health Research. She has published more than 180 scientific articles, with more than 4000 citations. She acts as an expert in the United Nations Environment Program and the World Health Organization. She has also established research and educational cooperation with several leading international universities such as ETH Zurich, University College London, Stanford, Columbia University, and the University of Saskatchewan.

Josef Loschmidt Chair Professor of Chemistry and Professor of Biochemistry at the Faculty of Science at Masaryk University in Brno, Czech Republic and a group leader at the International Centre for Clinical Research. Research of his group focuses on protein engineering. His group develops new concepts and software tools for protein engineering (CAVER, CAVERDOCK, HOTSPOT WIZARD, PREDICTSNP, FIREPROT, CALFITTER), and uses them for the computational design of enzymes. He has published >200 original articles, 18 book chapters and filed 7 international patents. He is a co-founder of the first biotechnology spin-off from Masaryk University - Enantis Ltd. Among the awards and distinctions, he has received the award EMBO/HHMI Scientist of the European Molecular Biology Organisation and the Howard Hughes Medical Institute.

Senior research scientist at Technical University Munich, Germany. He is working to understand the links between cancer and the aging process using his expertise in stem cells, high throughput sequencing technologies, and bioinformatics analysis. He was associated with the SENS research foundation and followed scientific development in the longevity field for many years. He has 10+ years of international research experience including a Ph.D. in Molecular Medicine from the German center for neurodegenerative diseases and the University of Goettingen in Germany. He authors in several high impact factor peer-reviewed publications such as Nature Neuroscience, Human molecular genetics, etc. He is also an entrepreneur and member of the Longevity investor network at Life extension advocacy foundation (LEAF) where he provides scientific assessments for longevity startups. He is also a founding member of the Longevity Accelerator.

A doctor with 30 years of experience in elite sports, especially in the field of fitness and bodybuilding. A specialist in athlete supplementation, a certified consultant and the head of an outpatient clinic in nutrition genetics, pharmacogenetics, sports and lifestyle genetics. Has worked for several international pharmaceutical companies (Glaxo, Yamanouchi, Krewel Meuselbach) and for the Czech Genetic Laboratory (Vemodia, KitGen), cooperating partner of several renowned European and American companies dealing with DNA analysis and telomere biology (DNA Plus, Novogenia, Life Length, T.A. Science). Physician of the Center for Medical Provision of Sports Representation in ÚVN Prague. A member of A4M (American Academy of Anti aging Medicine).

A generalist interested in building a better future. Co-founder of Longevityforum.eu, discussion platform aiming to bring the longevity topic into the mainstream starting in Czechia. He's written articles on topics including longevity and biohacking for Eccentric Club blog. He helps to steward the Foresight Institute Biotech & Health Extension world-class working group and is involved in the European Longevity Initiative. He has years of experience working in startups and attended the well-known 500 Startups accelerator in Silicon Valley. He is actively using his insight to build a personal portfolio of promising startups including Revolut, NowRx, Hypersciences, Small Robot Company, or LifeLength.

Having developed a curiosity for the biology of aging at an early age, Naftali has over eight years of experience conducting aging research in topics ranging from human genetics and gene editing to stem cell and tissue regeneration. He is currently pursuing a Ph.D. in the Harvard stem cell and regenerative biology department and holds a B.S. in molecular and cellular biology from Johns Hopkins University. He has also conducted research at the National Institute of Aging (NIA) and he currently serves as an intern and scientific advisor at LongevityTech.Fund.

Doctor, scientist and entrepreneur engaging in multiple facets of healthcare. His work in the Department of Hygiene and Preventive Medicine at Charles University in Prague focuses on aging. He acquired his knowledge of the longevity topic thanks to his own work and research as well as thanks to talking to the experts in the field and attending international conferences (i.e. Longevity World Forum in Valencia or EUROTOX in Helsinki). He co-authored a large number of publications in international impact journals. He also co-founded a startup trying to modernize primary care with the aim of enabling personalized and preventative medicine.